skinny.

Latest / Dr RR Baliga's "Got Knowledge Doc" Podkast

🛡️ One Risk Factor in Atrial Fibrillation: Is It Time for a DOAC?

đź«€ AF + just one stroke-risk factor: anticoagulate or not?

The SINGLE-AF randomized trial tackled this common clinical gray zone. At 24 months, the composite of stroke, systemic embolism, major bleeding, or cardiovascular death occurred in 0.5% with a DOAC vs 1.5% without anticoagulation (HR 0.31; P=0.03). 🎯

⚠️ Only 17 primary events occurred, so the effect estimate remains imprecise.

Anticoagulation for Atrial Fibrillation with Intermediate Stroke Risk.pdf

💡 Takeaway: SINGLE-AF strengthens the case for DOAC therapy in selected intermediate-risk AF patients—but individualized decision-making…

Log in to save or queue this episode.

The skinny

The skinny isn't ready yet — notes appear once the transcript is processed.